Tetrahydroberberine alleviates high-fat diet-induced hyperlipidemia in mice via augmenting lipoprotein assembly-induced clearance of low-density lipoprotein and intermediate-density lipoprotein
- 16 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 968, 176433
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515011014)
- National Natural Science Foundation of China (82074082, 82104472, 82374097)
This publication has 44 references indexed in Scilit:
- Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD MiceNeurotherapeutics, 2022
- Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemiaActa Pharmaceutica Sinica B, 2022
- The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular diseaseAtherosclerosis, 2021
- Metabolismo lipídico y clasificación de las hiperlipemiasClínica e Investigación en Arteriosclerosis, 2021
- Anti-hyperlipidemic potential of natural product based labdane-pyrroles via inhibition of cholesterol and triglycerides synthesisBioorganic Chemistry, 2021
- β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathwayBiomedicine & Pharmacotherapy, 2021
- Should We Target Global Risk or Risk Factors?Current Atherosclerosis Reports, 2021
- Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic DiseasesCurrent Atherosclerosis Reports, 2020
- Apolipoprotein E in Cardiovascular Diseases: Novel Aspects of an Old-fashioned EnigmaArchives of Medical Research, 2018
- Chiral hplc determination and stereoselective pharmacokinetics of tetrahydroberberine enantiomers in ratsChirality, 2012